EUCTR2017-000955-25-AT进行中（未招募）1 期
A single-centre, open-label, randomized controlled trial of efficacy, safety and usability of a basal insulin algorithm incorporated in the GlucoTab system compared to standard care for glycaemic management in geriatric patients with type 2 diabetes at acute geriatric care wards - Efficacy, safety and usability of the basal insulin algorithm within the GlucoTab system
Medical University of Graz0 个研究点目标入组 80 人开始时间: 2017年3月29日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Male or female aged = 65 years
- •Planned minimum stay of 1 week
- •Insulin planned as inpatient and/or discharge therapy
- •Type 2 diabetes (treated with diet, oral agents, non-insulin injected anti-diabetic medicine, insulin therapy or any combination of the four)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 80
排除标准
- •Instable corticosteroid therapy (>5 mg per day)
- •Known or suspected allergy to insulin glargine/ glulisine
- •Parenteral nutrition
研究者
相似试验
已完成
4 期
A single-centre, open-label, randomized controlled trial of efficacy, safety and usability of a basal insulin algorithm incorporated into the GlucoTab system compared to standard care for glycaemic management in geriatric patients with type 2 diabetes at acute geriatric care wardstype 2 diabetesE11Type 2 diabetes mellitusDRKS00012553Medizinische Universität GrazKlinische Abteilung für Endokrinologie und Diabetologie58
进行中（未招募）
不适用
A randomised, controlled, open-label, single-centre, parallel group,pilot study to investigate the onset of action of a lozenge comparedwith a caplet in patients with sore throat. - Strepsils onset of action studypatients with sore throatMedDRA version: 9.1Level: LLTClassification code 10041367Term: Sore throatEUCTR2006-006769-17-GBReckitt Benckiser Healthcare International Ltd60
招募中
不适用
A multi-center, open-label, randomized controlled clinical trial study on the treatment of Delta novel coronavirus pneumonia (COVID-19) based on ''three-party'' syndrome differentiation and treatmentDelta Novel Coronavirus PneumoniaITMCTR2100005149Affiliated Hospital of Nanjing University of Chinese Medicine (Jiangsu Province Hospital of Chinese Medicine)
已完成
不适用
Randomised controlled trial of early versus late ureteric stent removal post kidney transplantISRCTN51276329Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge (UK)350
进行中（未招募）
不适用
A single-center, open-label, controlled, randomized study to investigate the impact of a sequential oral contraceptive containing estradiol valerate and dienogest (SH T00658ID) as compared to a sequential oral contraceptive containing ethinylestradiol and levonorgestrel (SH D00264A) on plasma lipids, hemostatic variables, and carbohydrate metabolism in 60 healthy female volunteers aged 18-50 years over 7 treatment cycles - Metabolism study vs Triquilar 21+7ContraceptionEUCTR2004-001614-13-DESchering AG60